Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancer.
Erler P, Kurcon T, Cho H, Skinner J, Dixon C, Grudman S, Rozlan S, Dessez E, Mumford B, Jo S, Boyne A, Juillerat A, Duchateau P, Poirot L, Aranda-Orgilles B.
Erler P, et al.
Sci Adv. 2024 Aug 30;10(35):eadn9857. doi: 10.1126/sciadv.adn9857. Epub 2024 Aug 30.
Sci Adv. 2024.
PMID: 39213364
Free PMC article.